Exam Preview for 42279: A Robot Walks into a CI Center: What Audiol

A Robot Walks into a CI Center: What Audiologists Need to Know about iotaSOFT, Including Counseling Tips

Please note: exam questions are subject to change.

1. In the patient preference survey of candidates and recipients conducted by the Univ of Iowa, the participants all indicated an awareness of robotic surgery in general. Of the group, how many said they had an interest in learning more about robotic-assisted cochlear implantation? 80% 70% 55% 100%
2. In the Khan et al 2026 data, delayed onset hearing loss (DOHL) at 12 months post-activation was characterized by: 29% of the robotic-assisted cohort experienced DOHL, compared to 0% of the manual cohort and showed statistical significance of p=0.011. 29% of the robotic-assisted cohort experienced DOHL, compared to 0% of the manual cohort although this was not statistically significant. 0% of the robotic-assisted cohort experienced DOHL, compared to 29% of the manual cohort although there was no statistical significance. 0% of the robotic-assisted cohort experienced DOHL, compared to 29% of the manual cohort and showed statistical significance of p=0.011.
3. Which of the following best describes the clinical rationale for using post-operative acoustic thresholds as a "diagnostic proxy" for structural preservation following robotic-assisted cochlear implantation? Post-operative thresholds measure the electrical impedance of the electrode array to confirm correct scalar placement. Stable post-operative acoustic thresholds indicate that the elimination of manual insertion transients and pressure peaks has successfully maintained the delicate intracochlear architecture. Post-operative audiometric markers are used primarily to determine the appropriate MAPping levels for the speech processor’s T-coils. A reduction in post-operative thresholds suggests that the robotic system has increased the speed of insertion to prevent fibrotic tissue growth.
4. What risk factors did respondents identify as the biggest barrier to cochlear implantation? Waiting or technology to advance Hesitant about cost/insurance Worried about losing remaining hearing Nervous about surgery
5. The January 2026 FDA 510(k) clearance for the iotaSOFT Insertion System expanded the indication from 12 years and older to 4 years and older. Why is reducing intracochlear trauma particularly critical for the pediatric patient population (ages 4 and older)? Children will have for sure explanations and reimplantations of their cochlear implants in their lifetime. Doing less damage to the inner ear is important if there are medical advances in the future that they might be eligible. Robotic insertion is mandatory for pediatric patients because manual insertion is contraindicated by the FDA for children under age 12. Robotics can not be used in pediatrics of any age.